Almost half of the world’s population is now at risk for contracting dengue fever, also known as “breakbone fever,” an illness carried by a species of mosquitoes (Aedes aegyptia) that has recently expanded its range from tropical regions to more temperate ones in many parts of the United States.

A quarter of the people who become infected with dengue develop symptoms of illness — a potentially high fever, rash and severe muscle and joint pain. About 5% of those with symptoms develop severe dengue, which can become life-threatening within hours. The risk is even higher for infants and pregnant women.

No dengue vaccine is approved for use in the U.S., and no medication specific to dengue is available.



Julie Spencer is a researcher in the Information Systems and Modeling group at Los Alamos National Laboratory.

Recommended for you